Reporting J1444 under ESRD PPS

Reporting J1444 under ESRD PPS

In the quarterly update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), a new HCPCS Level II code is being added for anemia management with an effective date of July 1, 2019.
J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
This code is subject to Medicare Part B consolidated billing and, therefore, ESRD facilities will not receive separate payment for J1444 with or without modifier AY Item or service furnished to an ESRD patient that is not for the treatment of ESRD.
As will all drugs and biologicals that are furnished to ESRD patients via dialysate solution, append modifier JE Administered via dialysate to J1444 on bill type 72x.

MLN Matters MM11215

Renee Dustman
Follow me
Latest posts by Renee Dustman (see all)

About Has 746 Posts

Renee Dustman, BS, AAPC MACRA Proficient, is managing editor - content & editorial at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. Renee has more than 30 years' experience in journalistic reporting, print production, graphic design, and content management. Follow her on Twitter @dustman_aapc.

Comments are closed.